Candida meningitis. Course, prognosis and mortality before and after introduction of the new antimycotics.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy* / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D011379:Prognosis
D000935:Antifungal Agents; D000666:Amphotericin B; D005437:Flucytosine